ConductScience.org, home

Gene · 171221

NIH grants1,959

NIH grants whose papers are about the gene, through NIH's grant-paper links.

881 to 900 of 1,959

Download this page as JSON
GrantTitleDNAJB1P1 papersNewest fiscal year
R01CA172115The role of microRNA in oncogene-induced senescence and cancer development12018
R01CA172631Biopolymer-based strategies for local delivery of cytokine therapeutics12018
R01CA175033Host-tumor interactions and cancer relapse after radiation therapy12018
R01CA181450Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy12018
R01CA181808Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis12018
R01CA185297The aberrant androgen receptor underlies abiraterone/enzalutamide resistance12018
R01CA186662Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy12018
R01GM049369Function and regulation of the human splicing factor SC3512018
R01GM056350Exploring the toxicity of aggregates associated with protein-misfolding diseases12018
R01GM086386Regulation of microRNA Biogenesis in Stem Cells12018
R01GM087285Hepatic ER stress contributes to morbidity and mortality after burn injury.12018
R01GM093285Post-translational control mechanisms of the circadian clock12018
R01GM113251Interactions between Hsp90, Co-chaperones and Client Proteins12018
R01GM114166A yeast model of complex disease genetics12018
R01GM115634The Molecular Basis of Liquid-like Structure of the Nucleolus12018
R01HD057632Novel Gene Targets for CNS Axonal Regeneration12018
R01HD079327Novel Therapeutics against Respiratory Syncytial Virus Infection12018
R01HL123766Aging of Mesenchymal Stem Cells Missing Link in IPF12018
R01HL124773Novel mechanistic pathways of cardiovascular disease in obesity12018
R01HL125863Toward Diagnostics and Therapies of Molecular Subcategories of CAD12018

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/171221/grants?page=45